URGENT. The FDA did not approve any covid injection. They reissued the EUA. page 2.
More lies and propaganda to make you think approval happened. This is coercion at un-precedented levels. I will follow up on this later.
On August 23, 2021, FDA approved the biologics license application (BLA) submitted by BioNTech Manufacturing GmbH for COMIRNATY (COVID-19 Vaccine, mRNA) for active immunization to prevent COVID-19 caused by SARS-CoV-2 in individuals 16 years of age and older.
On August 23, 2021, having concluded that revising this EUA is appropriate to protect the public health or safety under section 564(g)(2) of the Act, FDA is reissuing the August 12, 2021 letter of authorization in its entirety with revisions incorporated to clarify that the EUA will remain in place for the Pfizer-BioNTech COVID-19 vaccine for the previously-authorized indication and uses, and to authorize use of COMIRNATY (COVID-19 Vaccine, mRNA) under this EUA for certain uses that are not included in the approved BLA.
FDA APPROVAL WAS JUST AN INDEFINITE EXTENSION OF EMERGENCY USE AUTHORIZATION (EUA) AND IS BASED ON 3 LIES
Denise M. Hinton, Chief Scientist at the FDA signed this letter, not granting full approval, but extending emergency use authorization "indefinitely." If you read the letter, these were her reasons:
▪︎A. SARS-CoV-2 can cause a serious or life-threatening disease or condition, including severe respiratory illness, to humans infected by this virus; [ Primarily in those with co-morbities ]
▪︎B. Based on the totality of scientific evidence available to FDA, it is "REASONABLE TO BELIEVE" that the Pfizer (jab) MAY BE effective in preventing COVID-19, and that, when used under the conditions described in this authorization, the known and potential benefits outweigh its known and potential risks; and [ WRONG ]
▪︎C. There is no adequate, approved, and available alternative to the emergency use of Pfizer [ LIES ]
On the last page it reads:
This EUA will be effective until the declaration that circumstances exist justifying the authorization of the emergency use of drugs and biological products during the COVID-19 pandemic is terminated under Section 564(b)(2) of the Act or the EUA is revoked under Section 564(g) of the Act.